The RNASEH1 gene helps cells remove stray RNA from RNA-DNA hybrids, especially in mitochondria, the parts of cells that make energy. This gene plays an important role in helping mitochondria copy and maintain their own DNA. If the gene does not work properly, mitochondrial DNA can become unstable, which may lead to muscle weakness, drooping eyelids, trouble moving the eyes, and other signs of a rare inherited mitochondrial condition. RNASEH1 is mainly known in clinical genetics rather than popular culture.
What is a gene?
Genes are sections of DNA that give your cells instructions for making molecules or guiding processes throughout the body. Some carry the code for proteins, which are the parts of cells that do much of the work. Others are mainly involved in regulating when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body grows and works, and they can influence how you respond to food, stress, and medicines. For a more detailed explanation of this topic, you can read more in the LearnHub.
Overview
RNASEH1Gene function
What if the gene works
The RNASEH1 gene makes a protein that removes RNA from mixed RNA-DNA strands, mainly in mitochondria. This helps mitochondrial DNA be copied and maintained, supporting normal energy production in cells.
Risk
What if the gene does not work
Variants in the RNASEH1 gene can impair mitochondrial DNA maintenance, leading most often to adult-onset progressive external ophthalmoplegia with drooping eyelids and limited eye movement; some people also develop muscle weakness or balance problems, and severity can vary by variant.
Treatment
What does that mean for your treatment
No RNASEH1-specific treatment or management approach is currently established. Research is exploring RNASEH1 in early stage drug development because some antisense medicines depend on RNASEH1 activity, but this does not yet guide treatment for people with pathogenic variants in the RNASEH1 gene.
Conditions associated with RNASEH1
Gene function
What if the gene works
Your cells constantly copy DNA and read it to make RNA. In this routine work, small RNA pieces can briefly stay attached to DNA and need to be cleared away. Understanding what the RNASEH1 gene does helps explain how cells keep this process smooth, especially inside mitochondria, the parts of cells that help make energy.
The RNASEH1 gene helps cells remove RNA that is temporarily attached to DNA. Clearing these mixed RNA-DNA structures helps DNA stay ready for normal copying and other routine cell work.
During DNA copying, short RNA starter pieces are placed to begin a new strand. RNASEH1 helps cut away these pieces after use so the DNA strand can be finished cleanly.
Inside mitochondria, the RNASEH1 gene supports the normal copying and upkeep of mitochondrial DNA, the small set of genetic instructions used in energy production. This helps those parts of the cell maintain their own DNA.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and are part of normal human diversity, including variation in appearance, metabolism, and the way the body reacts to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. Sometimes, though, a variant changes how a gene works more significantly and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Some variants in the RNASEH1 gene make the RNase H1 protein unstable or less active. This can leave cells less able to clear RNA-DNA hybrids (mixed RNA and DNA strands) and copy mitochondrial DNA. These RNASEH1 gene variant effects range from milder changes that leave some activity to more severe variants that remove most function. That difference can influence how much mitochondrial DNA maintenance is disrupted and when or how strongly RNASEH1-related disease shows up.
How variants are linked to conditions
Pathogenic variants in the RNASEH1 gene can cause a rare inherited mitochondrial disease that often includes progressive external ophthalmoplegia, where eye movements gradually become limited and eyelids may droop. Many people also have muscle weakness or tire easily with activity. Some develop balance, hearing, or swallowing problems. RNASEH1 gene variants and mitochondrial disease usually follow a recessive inheritance pattern, meaning the condition appears when both gene copies carry a pathogenic variant.
A variant is not necessarily a diagnosis
Genetic variants are a routine feature of human biology and are widely found across the general population. Most do not directly affect health and instead represent normal human diversity. In many genes, having a variant linked to a condition points to a possible association rather than a definite diagnosis, particularly when several genes and environmental factors play a role. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There isn't yet broadly confirmed evidence on specific factors that increase or reduce risk related to the RNASEH1 gene. For people with a disease-causing change in RNASEH1, risk is mainly shaped by the genetic change itself rather than lifestyle factors. Anyone worried about personal or family risk should speak with a doctor or genetic counselor.
Inheritance of RNASEH1 variants
For families looking into how RNASEH1 gene variants are inherited, the established pattern is autosomal recessive. This means a person usually needs to inherit two disease causing RNASEH1 variants, one from each parent, to have an RNASEH1 related condition. Parents who each carry one variant are typically unaffected carriers, and with each pregnancy there is a 25% chance their child will inherit both variants, a 50% chance the child will be a carrier, and a 25% chance the child will inherit neither familial variant.
What does my RNASEH1 result mean for my family?
For families, an RNASEH1 result usually matters most in a recessive pattern. Parents, brothers, sisters, and adult children may wish to learn whether they also carry the family’s RNASEH1 change, especially if there is a history of similar muscle weakness, drooping eyelids, or trouble moving the eyes. Close relatives are not all expected to have the condition, but some may be carriers without symptoms.
Genetic information
Genetic testing
How you find out about variants
Variants in the RNASEH1 gene are found with genetic testing, usually from a blood or saliva sample. A lab reads the gene’s DNA sequence, often as part of a mitochondrial disease panel or exome test, to look for variants in the RNASEH1 gene that may help explain symptoms or confirm a diagnosis.
When should I consider getting a genetic test?
Genetic testing for the RNASEH1 gene may be worth considering if someone has signs of a rare inherited mitochondrial condition, especially drooping eyelids, trouble moving the eyes, muscle weakness, or a family history of similar problems. Testing can help clarify whether RNASEH1 is the cause.
A genetic result is only one part of your health story
Genetic test results can offer useful insight, but how much they reveal depends on the condition and the specific type of variant involved. Over time, how the body functions is also shaped by many other factors, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most helpful when viewed alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put personal experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment works well for one person, has less effect in another, or causes more side effects in someone else. Part of the reason is that the body can absorb, break down, transport, or respond to a drug differently based on inherited differences, and these differences are common.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect a person’s response to medications. It studies the relationship between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence how the body processes a drug or how strongly it works. This information can support more informed, individualized treatment decisions. You can learn more about this topic in the LearnHub.
Drugs influenced by the RNASEH1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or adjusted. If you have questions about side effects, new symptoms, or how a treatment may affect you, talk with your doctor or pharmacist.
History
RNASEH1 entered the scientific literature through early work on RNase H activity, an enzyme activity identified in the 1960s and 1970s during basic DNA and RNA research. As medical science evolved, so did understanding of this gene, and researchers later showed that humans carry a specific RNASEH1 version with an important role in mitochondria. Interest in the RNASEH1 gene grew further as studies of antisense medicines showed how RNase H1 can help these treatments work inside cells. A later milestone came when inherited variants in the RNASEH1 gene were linked to mitochondrial disease, connecting years of laboratory research with patient care. These historical steps shaped today’s understanding of RNASEH1 as both a basic biology gene and a clinically relevant one.